European Patent Office Issues Its Intention to Grant Genervon Biopharmaceuticals a European Patent on Methods of Treating Neuronal Disorders Using MNTF Peptides and Analogs Thereof

The European Patent Office notified Genervon of its intention to grant a European patent on Methods of Treating Neuronal Disorders using MNTF peptides and analogs thereof. Genervon will proceed to have the patents for EPO application No. 07867451.2 issued, bringing the portfolio of Genervon's issued Composition of Matters and Use patents to 46...